AVE 0.00% 0.2¢ avecho biotechnology limited

financials have been released, page-22

  1. 564 Posts.
    lightbulb Created with Sketch. 1
    Whether its a SPP or a placement, that fact remains that POH still does not have a plan to fund Oxy through to commercialization and the March announcement of funding will not remove that uncertainty.




 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.